Medicinal products affected by serum potassium disturbances: periodic monitoring of serum potassium is recommended when Irbesartan Hydrochlorothiazide BMS is administered with medicinal products affected by serum potassium disturbances (e. g. digitalis glycosides, antiarrhythmics).
Det anbefales at måle serum- kalium periodisk, når Irbesartan Hydrochlorothiazide BMS administreres sammen med lægemidler, der påvirkes af serum- kaliumforstyrrelser (fx digitalisglykosider, antiarytmika).